Together with Curedatis, Climedo Health launched a new survey about clinical studies this summer. The survey aimed to analyze the specific challenges of clinical studies faced by pharmaceutical and medical device companies in the three main study stages (planning, implementation and close-out). In addition, we wanted to explore how much potential companies see in specific digital technologies and which trends in clinical studies they can envisage in the coming years.
60 participants from all over Europe, including numerous manufacturers from the medtech and pharmaceutical sector, gave their insights.
In addition, the survey specifically asked about experience in clinical studies before as well as after market approval.
The survey addressed the following areas:
If you have any questions about the results, please feel free to contact us at: email@example.com
Curedatis is a startup that digitalizes and automates the clinical evidence process to help medical device, In Vitro Diagnostics, and digital health companies meet the requirements for sufficient clinical evidence under the EU MDR, IVDR, and DiGAV. Learn more: www.curedatis.com.
About Climedo Health
Climedo Health's mission is to bring the best treatment to every patient by empowering healthcare professionals with intelligent software solutions. Together with Europe’s leading hospitals, we have developed a cloud-based platform for cutting-edge clinical validation and post-market surveillance of medical devices and pharmaceutical products.
By digitally connecting all stakeholders (Medical Device manufacturers, Pharma companies, CROs, hospitals and patients), Climedo allows for increased performance, better cost-efficiencies - and ultimately - accelerated medical innovation.
Learn more: www.climedo.de.